Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1152-1162

  Wang, Lai ^a   Su, Chen Yi ^a   Chou, Kuang Yu ^a   Wang, Cheng Teh ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Anticardiolipin antibodies; Collagen; Human platelet activation; Phospholipase C; Thromboxane A2

Indexed keywords

CALCIUM ION; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; COLLAGEN ANTIBODY; MYOSIN LIGHT CHAIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE C; PLECKSTRIN; THROMBOXANE B2;

ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; BLOOD PROTEINS; COLLAGEN; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; MYOSIN LIGHT CHAINS; PHOSPHOLIPASE C; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; RABBITS; THROMBOXANE B2; TIME FACTORS;

EID: 0036049079     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03739.x     Document Type: Article

References (52)

1. On the role of platelet Fc gamma RIIA phenotype in heparin-induced thrombocytopenia
2. Signal transduction by the platelet Fc receptor
3. Collagen increases cytoplasmic free calcium in human platelets
4. The pathogenesis of the anticardiolipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia
5. Lupus anticoagulants IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
6. Collagen stimulates tyrosine phosphorylation of phospholipase C-gamma2 but not phospholipase C-gamma1 in human platelets
7. Thrombosis and systemic lupus erythematosus despite circulating anticoagulant
8. Possible mechanisms of the potentiation of blood-platelet activation by adrenaline
9. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipod syndrome and with syphilis on platelet activation and aggregation
10. Evidence for a role of mysoin phosphorylation in the initiation of the platelet shape change response
11. Evidence for a role for tyrosine phosphorylation of phospholipase Cγ2 in collagen-induced platelet cytosolic calcium mobilization
12. Rapid, sensitive microassay for platelet 5HT
13. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation
14. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
15. Acquire inhibitors of blood coagulation
16. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
17. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies
18. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity
19. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain
20. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
21. 2 receptor antagonists
22. Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets
23. Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII
24. 2+ mobilization in human platelets
25. 1 integrin is a necessary co-receptor for collagen-induced activation of syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets
26. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent collagen
27. Signal transduction by integrins: Increased protein tyrosine phosphorylation caused by clustering of α2β1 integrins
28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
29. +
30. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y (1) receptor-null mice
31. 2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets
32. Activation of human platelets by the rabbit anticardiolipin antibodies
33. Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): Standardization and quantitation of results
34. 2-glycoprotein I (apoliprotein H)
35. Hemostatic defect due to platelet cyclooxygenase deficiency
36. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation
37. The mechanism of arachidonic acid release in collagen-activated human platelet
38. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus
39. 2+ ionophore A23187 synergistically induce platelet aggregation without protein kinase C activation
40. Differences in functional activity of anticardiolipid antibodies from patients with syphilis and those with antiphospholipid syndrome
41. 3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen
42. Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system
43. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions
44. Role of FcγRII in platelet activation by monoclonal antibodies
45. 2+ concentration
46. New diagnostic strategies for lupus anticoagulants and antipholipid antibodies
47. Changes in both calcium pool size and morphology of human platelets incubated in various concentrations of calcium ion. Calcium-specific bleb formation on platelet-membrane surface
48. A novel association of Fc receptor γ chain with glycoprotein VI and their coexpression as a collagen receptor in human platelets
49. Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies
50. 2+ and protein kinase C is the major factor in determining the level of secretion from human platelets
51. Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium
52. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the FcγIIA receptor